Akre Focus ETF Attracts $18.6M in Q4 Stakes from Two Asset Managers
Oklahoma-based JBR Co Financial Management acquired 108,793 shares of the Akre Focus ETF in Q4 valued at $7.13 million at quarter-end pricing. Canal Capital Management added 175,232 shares worth $11.5 million, representing 2.98% and 1.6% of their respective 13F portfolios.
1. Oklahoma-Based Adviser Adds $7.13 Million Stake in Akre Focus ETF
JBR Co Financial Management established a new position in the Akre Focus ETF during the fourth quarter, acquiring 108,793 shares for an estimated $7.13 million based on quarter-end valuation. The stake represents 2.98% of JBR’s 13F-reportable assets under management as of December 31. Following the transaction, the ETF’s top five holdings by market value were NVidia at $34.79 million (14.7% of AUM), the SPDR Bloomberg 1-3 Month T-Bill ETF at $12.10 million (5.1%), the Vanguard Information Technology ETF at $11.78 million (5.0%), the SPDR Portfolio S&P 500 ETF at $10.87 million (4.6%), and the Invesco NASDAQ 100 ETF at $9.52 million (4.0%). The fund offers a concentrated portfolio of U.S. equities, warrants and cash equivalents, selects foreign securities and alternative instruments, with a disciplined process focused on business quality, strong shareholder returns and reinvestment potential.
2. Canal Capital Management Initiates $11.5 Million Position in Akre Focus ETF
Canal Capital Management, LLC disclosed on January 6 that it acquired 175,232 shares of the Akre Focus ETF during the fourth quarter, representing an estimated $11.5 million investment and accounting for 1.6% of its total assets under management. After the purchase, the ETF’s largest allocations in Canal’s reportable portfolio included Old Dominion Freight Line at $58.79 million (8.3% of AUM), Apple at $34.81 million (4.9%), Microsoft at $26.07 million (3.7%), the iShares iBoxx $ Investment Grade Corporate Bond ETF at $20.15 million (2.9%) and Broadcom at $19.06 million (2.7%). The Akre Focus ETF continues to operate with a non-diversified mandate and a 0.98% expense ratio, maintaining a high-conviction, research-driven strategy across the capital structure with clear sell criteria and a focus on long-term compounders rather than broad benchmark tracking.